본문 바로가기

Efficacy and Tolerability of Anticholinergics in Korean Children with Overactive Bladder: A Multicenter Retrospective Study

문서 유형
연구출판물 · 학술지 논문
등재
KCISCIEScopus
저널 순위
JCR Q3Scopus Q2
저널
JOURNAL OF KOREAN MEDICAL SCIENCE29(11) · pp.1550 · 2014
피인용
Web of Science 13KCI 1
JCR IF
JCR 2013 1.253
ISSN
1011-8934

저자

  1. Park, Se Jin제1저자아주대학교, Ajou Univ Hosp, Sch Med, KO
  2. Pai, Ki Soo아주대학교, Ajou Univ Hosp, Sch Med, KO
  3. Kim, Jun Mo순천향대학교, Soonchunhyang Univ Hosp, Coll Med, KO
  4. Park, Kwanjin서울대학교, Coll Med, Dept Urol, KO
  5. Kim, Kun Suk울산대학교, Coll Med, Asan Med Ctr, KO
  6. Song, Sang Hoon울산대학교, Coll Med, Asan Med Ctr, KO
  7. Park, Sungchan교신저자울산대학교, Chonnam Natl Univ Hosp, Sch Med, KO
  8. Kim, Sun-Ouck성균관대학교, 의과대학, 의학과, KO
  9. Ryu, Dong Soo성균관대학교, Samsung Changwon Hosp, Sch Med, KO
  10. Baek, Minki성균관대학교, Sch Med, Samsung Med Ctr, KO
  11. 이상돈부산대학교, 의과대학, 의학과, 비뇨기과학교실, KO
  12. Lee, Jung Won한림대학교, Kangnam Sacred Heart Hosp, Dept Pediat, KO
  13. Im, Young Jae연세대학교, Coll Med, Urol Sci Inst, KO
  14. Han, Sang Won연세대학교, Coll Med, Urol Sci Inst, KO
  15. 정재민부산대학교, 의과대학, 의학과, KO
  16. Cho, Min Hyun경북대학교, Sch Med, Dept Pediat, KO
  17. Ha, Tae-Sun충북대학교, Coll Med, Dept Pediat, KO
  18. Cho, Won Yeol동아대학교, Dept Urol, KO
  19. Suh, Hong Jin가톨릭대학교, Incheon St Marys Hosp, Dept Urol, KO

초록

We investigated the efficacy and tolerability of various anticholinergics in Korean children with non-neurogenic overactive bladder (OAB). A total of 326 children (males: females = 157: 169) aged under 18 yr (mean age 7.3 +/- 2.6 yr) who were diagnosed with OAB from 2008 to 2011 were retrospectively reviewed. The mean duration of OAB symptoms before anticholinergic treatment was 16.9 +/- 19.0 months. The mean duration of medication was 5.6 +/- 7.3 months. Urgency urinary incontinence episodes per week decreased from 1.9 +/- 3.1 to 0.4 +/- 1.5 times (P < 0.001). The median voiding frequency during daytime was decreased from 9.2 +/- 5.4 to 6.3 +/- 4.2 times (P < 0.001). According to 3-day voiding diaries, the maximum and average bladder capacity were increased from 145.5 +/- 66.9 to 196.8 +/- 80.3 mL and from 80.8 +/- 39.6 to 121.8 +/- 56.5 mL, respectively (P < 0.001). On uroflowmetry, maximum flow rate was increased from 17.6 +/- 8.4 to 20.5 +/- 8.2 mL/sec (P < 0.001). Adverse effects were reported in 14 (4.3%) children and six children (1.8%) discontinued medication due to adverse effects. Our results indicate that anticholinergics are effective to improve OAB symptoms and tolerability was acceptable without severe complications in children.

키워드

Overactive Urinary BladderUrinary IncontinenceAnticholinergicsEfficacyTolerabilityURINARY-TRACT FUNCTIONCONTINENCE-SOCIETYSTANDARDIZATIONINCONTINENCECOMMITTEETERMINOLOGYPROPIVERINEOXYBUTYNINSAFETY

식별자

WoS UID
000345321400017
KCI
ART001928182